Costs, Innovation and Efficiency in Anti-Infective Therapy
- 1 January 1996
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 9 (1) , 31-39
- https://doi.org/10.2165/00019053-199600091-00007
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cost of Treatment and Prevention of Haemophilus influenzae Type b DiseasePharmacoEconomics, 1994
- Cost Analysis of Imipenem-Cilastatin Versus Clindamycin with Tobramycin in the Treatment of Acute Intra-Abdominal InfectionPharmacoEconomics, 1993
- Should adult tetanus immunization be given as a single vaccination at age 65?Journal of General Internal Medicine, 1993
- Oral CiprofloxacinPharmacoEconomics, 1993
- Pharmacoeconomics of ImmunisationPharmacoEconomics, 1993
- Prescription Cost SharingPharmacoEconomics, 1992
- Review of Cost-Benefit Analyses of Influenza VaccinePharmacoEconomics, 1992
- Institutional FormulariesPharmacoEconomics, 1992
- Pharmacoeconomics of Genetically Engineered DrugsPharmacoEconomics, 1992
- What is the Cost of Nephrotoxicity Associated with Aminoglycosides?Annals of Internal Medicine, 1987